{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:14:44Z","timestamp":1762161284029,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jfo.2016.10.010","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T04:16:38Z","timestamp":1488255398000},"page":"202-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antiangiogenic activity of a bevacizumab-loaded polyurethane device in animal neovascularization models"],"prefix":"10.1016","volume":"40","author":[{"given":"A.E.R.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.F.M.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.C.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.D.","family":"Cassali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.O.","family":"Fulg\u00eancio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ayres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.L.","family":"Or\u00e9fice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Silva-Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8068-5211","authenticated-orcid":false,"given":"S.L.","family":"Fialho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2016.10.010_bib0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1158\/0008-5472.671.65.3","article-title":"Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies","volume":"65","author":"Gerber","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jfo.2016.10.010_bib0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.jfo.2016.10.010_bib0115","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ajo.2012.06.007","article-title":"Short-term topical bevacizumab in the treatment of stable corneal neovascularization","volume":"154","author":"Cheng","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2016.10.010_bib0120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jfo.2016.10.010_bib0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0169-409X(95)00014-X","article-title":"Ocular inserts for topical delivery","volume":"16","author":"Saettone","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jfo.2016.10.010_bib0130","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1098\/rstb.2004.1500","article-title":"Protein structure, stability and solubility in water and other solvents","volume":"359","author":"Pace","year":"2004","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.jfo.2016.10.010_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.11.014","article-title":"Protein aggregation and its inhibition in biopharmaceutics","volume":"289","author":"Wang","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jfo.2016.10.010_bib0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0006-3495(00)76602-1","article-title":"The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein","volume":"78","author":"Vermeer","year":"2000","journal-title":"Biophys J"},{"key":"10.1016\/j.jfo.2016.10.010_bib0145","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/jps.21566","article-title":"Protein aggregation: pathways, induction factors and analysis","volume":"98","author":"Mahler","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jfo.2016.10.010_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpharm.2013.04.063","article-title":"Polyurethane-based drug delivery systems","volume":"450","author":"Cherng","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jfo.2016.10.010_bib0155","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1016\/j.eurpolymj.2007.05.014","article-title":"Phase morphology of hydrolysable polyurethanes derived from aqueous dispersions","volume":"43","author":"Ayres","year":"2007","journal-title":"Eur Polym J"},{"key":"10.1016\/j.jfo.2016.10.010_bib0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.msec.2010.10.019","article-title":"Biodegradable polyurethane nanocomposites containing dexamethasone for ocular route","volume":"31","author":"Da Silva","year":"2011","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.jfo.2016.10.010_bib0165","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s10856-013-4885-6","article-title":"Montmorillonite clay based polyurethane nanocomposite as substrate for retinal pigment epithelial cell growth","volume":"24","author":"Da Silva","year":"2013","journal-title":"J Mater Sci Mater Med"},{"key":"10.1016\/j.jfo.2016.10.010_bib0170","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1167\/iovs.15-18127","article-title":"Anti-inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats","volume":"57","author":"Saliba","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2016.10.010_bib0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0959-9673.2004.00396.x","article-title":"Current methods for assaying angiogenesis in vitro and in vivo","volume":"85","author":"Staton","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.jfo.2016.10.010_bib0180","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","article-title":"Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2016.10.010_bib0185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0420.2007.01049.x","article-title":"Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn","volume":"86","author":"Yoeruek","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2016.10.010_bib0190","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/bjc.1995.331","article-title":"Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma","volume":"72","author":"Maeda","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jfo.2016.10.010_bib0195","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/S0004-27492011000100011","article-title":"A\u00e7\u00e3o do bevacizumabe subconjuntival na neovasculariza\u00e7\u00e3o e re-epiteliza\u00e7\u00e3o corneana 25 dias ap\u00f3s queimadura qu\u00edmica","volume":"74","author":"Mello","year":"2011","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.jfo.2016.10.010_bib0200","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1167\/iovs.09-4140","article-title":"Pharmacokinetics of bevacizumab and its effect on vascular endothelial growth factor after intravitreal injection of bevacizumab in macaque eyes","volume":"51","author":"Miyake","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217300281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217300281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:07:17Z","timestamp":1759259237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551217300281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0181551217300281"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2016.10.010","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiangiogenic activity of a bevacizumab-loaded polyurethane device in animal neovascularization models","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}